… We aim to provide new insights into the pharmacological … Bipolar disorder is a chronic
episodic mental disorder … the subjective light phase of rats exposed to chronic constant light. …

… or other pharmacologic treatments in the acute and maintenance … for acute phase or
maintenance phase bipolar disorder, … for the management of patients with bipolar disorder: update …

… After the primary injury, the acute secondary injury phase … effective drug for preventing the
recurrence of bipolar disorder (… US Food and Drug Administration (FDA)-approved drug as a …

… , damage occurs in the acute phase of injury that leads to the … The US Food and Drug
Administration has yet to approve … individual and yet cause severe, chronic outcomes in another. …

… factor administration, together with poor penetrance of the blood-brain barrier that impairs
drug … Furthermore, NGF produced during the acute and chronic phase of the disease, may be …

… at baseline (acute phase), 48 hours (mid-epileptogenesis), and 4 weeks (chronic epilepsy) …
of MRP1; the ADT after drug administration in the rats with overexpression of miR-139-5p or …

… While the simple gangliosides GM3 and GD3 predominate in earlier stages, more-complex …
the same drug, at 28 centers in North America, including 760 patients with acute spinal cord …

… -based standardized mental disorders management onpatients with severe mental … in treating
mental illness in bipolar disorder[J]. Chinese Pharmaceutical Affairs, 2018, 32(6): 799-803. …

… Finally, in inflammatory bowel disease patients, a phase II trial with GSK2330811 on Crohn’…
drug administration is an emerging drug delivery route in the field of neurological disease. …

… 25 at early stages to as low as 20/800 in advanced stages. The ProgStar … , management is
focused on monitoring the disease and … The pharmacologic strategies are primarily focused on …